ZYDUSLIFE — Zydus Lifesciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Zydus Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	12,464	12,816	40,818	11,876	20,149
Net Total Accounts Receivable
Net Total Receivables	43,564	38,518	39,395	50,816	52,217
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	87,154	87,160	122,614	100,164	115,014
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	61,937	63,332	64,226	68,267	69,148
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	236,866	238,847	277,954	257,564	292,808
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	82,694	78,613	78,394	55,307	53,419
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	133,109	108,924	107,958	82,406	94,513
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	103,757	129,923	169,996	175,158	198,295
Total Liabilities & Shareholders' Equity	236,866	238,847	277,954	257,564	292,808
Total Common Shares Outstanding